These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14608350)

  • 1. [Potentialities of treating secondary dysthymia with painful dysfunction of temporomandibular joint].
    Gorozhankina EA; Markov BP; Mamedov FM
    Stomatologiia (Mosk); 2003; 82(5):44-7. PubMed ID: 14608350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quality of life as the criterion of psychological status of patients with painful dysfunction of the temporomandibular joint].
    Mamedov FM; Markov BP; Gorozhankina EA
    Stomatologiia (Mosk); 2004; 83(4):65-7. PubMed ID: 15340309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of mild depression in elderly patients.
    Terluin B; van Hout H
    JAMA; 2000 Dec; 284(23):2993-4; author reply 2994. PubMed ID: 11122575
    [No Abstract]   [Full Text] [Related]  

  • 4. The long-term outcome of dysthymia in private practice: clinical features, temperament, and the art of management.
    Haykal RF; Akiskal HS
    J Clin Psychiatry; 1999 Aug; 60(8):508-18. PubMed ID: 10485632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of venlafaxine in the treatment of primary dysthymia.
    Ravindran AV; Charbonneau Y; Zaharia MD; al-Zaid K; Wiens A; Anisman H
    J Psychiatry Neurosci; 1998 Nov; 23(5):288-92. PubMed ID: 9846033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of mild depression in elderly patients.
    Leard-Hansson J
    JAMA; 2000 Dec; 284(23):2993; author reply 2994. PubMed ID: 11122574
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug treatments for patients with dysthymia.
    Kripke C
    Am Fam Physician; 2004 Oct; 70(7):1269-70. PubMed ID: 15508536
    [No Abstract]   [Full Text] [Related]  

  • 8. Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation.
    Bogetto F; Bellino S; Revello RB; Patria L
    CNS Drugs; 2002; 16(4):273-83. PubMed ID: 11945110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.
    von Wolff A; Hölzel LP; Westphal A; Härter M; Kriston L
    J Affect Disord; 2013 Jan; 144(1-2):7-15. PubMed ID: 22963896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertraline and imipramine for the treatment of dysthymia.
    de Jonghe F
    Arch Gen Psychiatry; 1997 Oct; 54(10):973. PubMed ID: 9337782
    [No Abstract]   [Full Text] [Related]  

  • 11. Orphan comparisons and indirect meta-analysis: a case study on antidepressant efficacy in dysthymia comparing tricyclic antidepressants, selective serotonin reuptake inhibitors, and monoamine oxidase inhibitors by using general linear models.
    Ballesteros J
    J Clin Psychopharmacol; 2005 Apr; 25(2):127-31. PubMed ID: 15738743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of dysthymia.
    Buni TM
    J Fam Pract; 1997 Jun; 44(6):528-9. PubMed ID: 9191617
    [No Abstract]   [Full Text] [Related]  

  • 13. SSRI-associated sexual dysfunction.
    Balon R
    Am J Psychiatry; 2006 Sep; 163(9):1504-9; quiz 1664. PubMed ID: 16946173
    [No Abstract]   [Full Text] [Related]  

  • 14. Geriatric dysthymia.
    Kocsis JH
    J Clin Psychiatry; 1998; 59 Suppl 10():13-5. PubMed ID: 9720477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
    Ravindran AV; Guelfi JD; Lane RM; Cassano GB
    J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tachyphylaxis/tolerance to antidepressants in treatment of dysthymia: results of a retrospective naturalistic chart review study.
    Katz G
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):499-504. PubMed ID: 21851459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide.
    Versiani M
    J Affect Disord; 1998 Dec; 51(3):323-32. PubMed ID: 10333986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review: SSRIs and TCAs equally effective at treating chronic depression and dysthemia; SSRIs are associated with fewer adverse events than TCAs.
    Kocsis JH
    Evid Based Ment Health; 2013 Aug; 16(3):82. PubMed ID: 23604275
    [No Abstract]   [Full Text] [Related]  

  • 19. Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence.
    De Lima MS; Hotopf M
    Drug Saf; 2003; 26(1):55-64. PubMed ID: 12495364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--"double depression"].
    Ladeira RB; Cunha FT; Salgado JV; Teixeira AL; Nicolato R
    Braz J Psychiatry; 2008 Sep; 30(3):299-300. PubMed ID: 18833439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.